Alamgir Khan

Dr. Alamgir Khan serves as an Adjunct Senior Lecturer at the School of Biotech & Biomolecular Science, University of New South Wales. With a research career spanning over two decades, his work bridges multiple scientific disciplines including proteomics, molecular biology, immunology, and systems biology. His academic contributions are primarily focused on biomarker discovery and advanced proteomic methodologies.

Dr. Khan's research interests center on proteomic analysis techniques, particularly in the development and refinement of multiplex immunoassays for biomarker discovery. His work spans diverse applications including cancer diagnostics, sports medicine (particularly anti-doping research), plant pathology, and yeast biology. He has made significant contributions to understanding cytokine profiling across various biological fluids and has developed methodologies for high-abundance protein depletion in plasma samples, which has advanced biomarker discovery in clinical settings.

Analysis of Dr. Khan's publication record reveals consistent contributions to proteomics methodology development, with particular emphasis on multiplex immunoassay technologies and statistical approaches for data interpretation. His research shows a clear trajectory from fundamental molecular biology studies toward clinical applications, with significant work in cancer biomarkers, endometriosis diagnostics, and sports pharmacology. The interdisciplinary nature of his work demonstrates strong connections between basic science and practical applications across medicine, agriculture, and food science.

Dr. Khan has collaborated extensively with researchers across multiple institutions, evidenced by his numerous co-authored publications. His work has appeared in high-impact journals across proteomics, molecular biology, immunology, and clinical diagnostics fields.